SCHEMBL18031007

SCHEMBL18031007

Cn1c2ccccc2c2ccc(-n3c4cc(C#N)ccc4c4ccc(C#N)cc43)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.46
▸ L3MBTL1 Q9Y468 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ TLR9 Q9NR96 1/20 0.45
▸ KIF11 P52732 1/20 0.43
▸ POLB P06746 2/20 0.41
▸ PTPN7 P35236 1/20 0.41
▸ DUSP3 P51452 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ HPGD P15428 4/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ SRC P12931 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18031026 0.99 GPR3 (0.44) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL17034461 0.96 L3MBTL1 (0.43) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL18055719 0.94 L3MBTL1 (0.41) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL18030981 0.93 GPR3 (0.44) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL17034395 0.92 GPR3 (0.43) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL18031027 0.92 GPR3 (0.43) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL17034462 0.92 GPR3 (0.43) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL18031009 0.92 GPR3 (0.43) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL18031004 0.92 GPR3 (0.43) GPR3L3MBTL1KMT2AMEN1TLR9
SCHEMBL17032695 0.89 GPR3 (0.57) GPR3L3MBTL1KMT2AMEN1TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3061759-B1 NITRILE SUBSTITUTED DIBENZOFURANS IDEMITSU KOSAN CO (JP) 2019-12-25 — — EP disclosed
EP-3119770-B1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES IDEMITSU KOSAN CO (JP) 2018-05-02 — — EP disclosed
US-20170098781-A1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES IDEMITSU KOSAN CO., LTD. (JP) 2017-04-06 — — US disclosed
US-20160248026-A1 NITRILE SUBSTITUTED DIBENZOFURANS IDEMITSU KOSAN CO., LTD. (JP) 2016-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170098781-A1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES DBF4, DDT, SLC43A3 GPR3 4658/4885L3MBTL1 2157/4885KMT2A 3930/4885
US-20160248026-A1 NITRILE SUBSTITUTED DIBENZOFURANS DBF4, NXF1, NCF1 GPR3 4779/4885L3MBTL1 2762/4885KMT2A 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback